Industry Experts

David is the development group leader at Coding Bio in Oxford. With a career forged in industrial R&D across startups and multinational companies, his expertise lies in antibody discovery and engineering. Career highlights include being the first inventor on the patent for bepranemab, UCB’s anti-Tau monoclonal, and being a member of the original team at DJS Antibodies when the company was acquired by AbbVie. When at Immunocore, he worked on diagnostic antibodies and TCR mimic monoclonals. David’s research had spanned therapeutic areas such as neurology, infectious diseases, fibrotic diseases, and oncology.